Regenerative Medicine Foundation

Facilitating the development and cures for diseases through the science of regenerative medicine


Home

Register today: April 6-8, 2010: Translational Regenerative Medicine Forum, Winston-Salem, NC

Agenda

Tuesday, April 6th

4:00–6:00 pm Conference Registration and Networking
6:00–7:30 pm Opening Reception  

Wednesday, April 7th

7:30–8:30 am Networking Breakfast
8:30–8:45 am Welcome and Opening Remarks
  Welcome Anthony Atala, MD,
Wake Forest Institute for Regenerative Medicine
    Al Delia,
Chairman of the Innovation Council
Office of Governor Beverly Perdue
8:45–9:15 am What Is the Promise of Regenerative Medicine?
  Format: Panel
  Moderator John E. Abele, Founding Chairman, Retired,
Boston Scientific Corporation
  Panelist Alan J. Lewis, PhD,
Juvenile Diabetes Research Foundation International
  Panelist John Walker, iPierian
  Panelist Andrew von Eschenbach, MD,
Greenleaf Health LLC and Center for Health Transformation
Former US FDA Commissioner
  Panelist Gary J. Kurtzman, MD,
Safeguard Scientifics
9:15–10:00 am The Translational Imperative: Deliver the Promise
  Format: Panel  
  Moderator Lesa Mitchell,
Kauffman Foundation
  Panelist Brock Reeve, MPhil, MBA,
Harvard Stem Cell Institute
  Panelist Scott Weir, PharmD, PhD,
University of Kansas, Institute for Advancing Medical Innovation
  Panelist Rick Blume, Excel Medical Ventures
10:00–10:30 am Networking Break  
10:30–11:15 am The Science: What’s Next for the Clinic?
  Format: Plenary, Keynote Address Robert Lanza, MD,
Advanced Cell Therapy
11:15 am–noon Bridging: From the Bench to the Bedside
  Format: Panel  
  Moderator Michael J. Werner,
Holland & Knight
  Panelist Bernard Siegel,
Genetics Policy Institute
  Panelist COL Janet R. Harris, PhD, MSN,
AFIRM
Congressionally Directed Medical Research Programs
  Panelist DaLaura L.S. Kader,
Regenerative Medicine Foundation
  Panelist Michelle McMurry-Heath, MD, PhD,
The Aspen Institute
  Panelist Rosemarie Hunziker, PhD,
National Institute of Biomedical
Imaging and Bioengineering, National Institutes of Health
noon–12:30 pm Lunch  
12:30–1:15 pm A Funding Model for Translational Medicine  
  Format: Keynote Address Robert Klein,
California Institute for Regenerative Medicine (CIRM)
1:15–2:00 pm Integrative Commercialization Strategies
  Format: Panel  
  Moderator Scott R. Burger, MD,
Advanced Cell & Gene Therapy
  Panelist Stephen Minger, PhD,
GE Healthcare
  Panelist Steven R. Bauer, PhD,
US Food and Drug Administration
  Panelist Vincent Ronfard, PhD,
Organogenesis
  Panelist Joydeep Goswami, PhD, MBA,
Life Technologies
  Panelist Tim Bertram, DVM, PhD, Tengion
2:00–2:45 pm Regulatory and Reimbursement Strategies
  Format: Panel  
  Moderator Andrew von Eschenbach, MD,
Greenleaf Health LLC and Center for Health Transformation
Former US FDA Commissioner
  Panelist Steven R. Bauer, PhD,
US Food and Drug Administration
  Panelist Anthony Ratcliffe, PhD,
Synthasome
  Panelist Richard E. Caruso, PhD, Integra
2:45–3:15 pm International Best Practices in Regenerative Medicine
  Format: Panel  
  Moderator David F. Williams, DSc, FREng,
Wake Forest Institute for Regenerative Medicine
  Panelist Prof. Chunren Wang,
National Institute for the Control of
Pharmaceutical and Biological Products
  Panelist COL Robert Vandre, DDS, AFIRM
  Panelist Mime Egami, PhD,
Tokyo Women’s Medical University
3:15–3:35 pm Networking Break  
3:35–5:30 pm Scientific Discovery  
  Format: Podium Presentations  
  Host and Presenter Buddy D. Ratner, PhD,
University of Washington
  Presenter Teruo Okano, PhD,
Tokyo Women’s Medical University
  Presenter Jennifer H. Elisseeff, PhD,
Johns Hopkins University
  Presenter Jack Kessler, MD,
Northwestern University
  Presenter G. Sitta Sittampalam, PhD,
University of Kansas,
Institute for Advancing Medical Innovation
  Presenter Douglas Losordo, MD, FACC, Northwestern University
  Presenter Simon Cool, PhD,
A*STAR Singapore
  Presenter B. Lynn Allen-Hoffmann, PhD,
Stratatech Corporation
  Presenter Yilin Cao, MD, PhD,
Shanghai Jiao Tong University
5:30–6:30 pm Networking Reception  
  Poster Session  
7:00–8:30 pm Gala Dinner  
  Keynote Address: Juan Enriquez,
Excel Venture Management

Thursday, April 8th

7:00–8:00 am Breakfast and Venture Forum I
  Company Arterion
  Company Articular Engineering
  Company Creative Bioreactor Designs, Inc.
  Company ISTO Technologies
  Company KeraNetics
  Company Kryosphere
  Company Southern Access Technologies
  Company Ventrix
8:00–8:30 am Translational Medicine in the Military
  Format: Plenary, Keynote Address
    Lieutenant General
Eric B. Schoomaker, MD, PhD,
US Army Medical Command
8:30–9:15 am Best Practices in Commercialization
  Format: Panel
  Moderator R. Lee Buckler, BEd, LLB,
Cell Therapy Group
  Panelist Anthony Caggiano, MD, PhD,
Acorda Therapeutics
  Panelist Dean Tozer,
Advanced BioHealing
  Panelist Ed Field, Aldagen
  Panelist Robert Deans, PhD, Athersys
  Panelist Richard S. Stack, MD, FACC,
Synecor
9:15–9:45 am Commercial Capacity and Tools
  Format: Panel
  Moderator Edmund “Morrie” Ruffin, MA,
Adjuvant Global Advisors
  Panelist Raymond H. Cypess, DVM, PhD,
ATCC
  Panelist Joseph DeSimone, PhD,
Liquidia Technologies
  Panelist Kurt Last,
Specialty Operations Solutions
  Panelist David S. Smith,
Pepper Hamilton LLP
9:45–10:20 am Venture Panel I: Designing the Deal
  Format: Panel
  Moderator Jeff Karan, MBA
Proteus Ventures Partners
  Panelist Garheng Kong, MD, PhD,
Intersouth Partners
  Panelist Frank Douglas, MD, PhD,
Pure Tech Ventures,
Austen BioInnovation Inst. in Akron,
Kauffman Foundation  
  Panelist Mostafa Analoui, PhD,
Livingston Group
  Panelist Gail K. Naughton, PhD,
Histogen
10:20–11:00 am Venture Panel II: Capturing Value for Capital Markets
  Format: Panel  
  Panelist Jay Watkins,
De Novo Ventures
  Panelist Scott Livingston,
Livingston Securities
  Panelist Rick Blume,
Excel Medical Ventures
  Panelist P. Sherrill Neff,
Quaker BioVentures
  Panelist David Scheer,
Scheer & Company
11:00–11:15 am Networking Break
11:15 am–12:55 pm Venture Forum II
  Company ACell
  Company Avita Medical
  Company Bioheart
  Company Healionics
  Company Juventas Therapeutics
  Company Ocular Systems
  Company PharmInova
  Company Soft Tissue Regeneration
  Company America Stem Cell
  Company Axerion Therapeutics     

12:55–1:00 pm Wrap Up and Adjourn Meeting Anthony Atala, MD,
Wake Forest Institute for Regenerative Medicine